Cargando…

Retraction

Retraction: Yang, Y, Zheng, J, Wang, M, et al. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling. Cancer Sci. 2021; 112: 641–654. https://doi.org/10.1111/cas.14744. The above article, published online on 22 November 2020 in Wiley Online Library (wile...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323109/
https://www.ncbi.nlm.nih.gov/pubmed/37211924
http://dx.doi.org/10.1111/cas.15809
_version_ 1785068897667383296
collection PubMed
description Retraction: Yang, Y, Zheng, J, Wang, M, et al. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling. Cancer Sci. 2021; 112: 641–654. https://doi.org/10.1111/cas.14744. The above article, published online on 22 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor‐in‐Chief, Masanori Hatakeyama, the Japanese Cancer Association and John Wiley and Sons Australia, Ltd. The retraction has been agreed following concerns raised by a third party about figures within the article. During the journal's investigation into the concerns raised, the authors were not able to provide comprehensive original data for the figures in concern. Accordingly, the editorial team considers the conclusions of this manuscript insufficiently supported.
format Online
Article
Text
id pubmed-10323109
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103231092023-07-07 Retraction Cancer Sci Retraction Retraction: Yang, Y, Zheng, J, Wang, M, et al. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling. Cancer Sci. 2021; 112: 641–654. https://doi.org/10.1111/cas.14744. The above article, published online on 22 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor‐in‐Chief, Masanori Hatakeyama, the Japanese Cancer Association and John Wiley and Sons Australia, Ltd. The retraction has been agreed following concerns raised by a third party about figures within the article. During the journal's investigation into the concerns raised, the authors were not able to provide comprehensive original data for the figures in concern. Accordingly, the editorial team considers the conclusions of this manuscript insufficiently supported. John Wiley and Sons Inc. 2023-05-22 /pmc/articles/PMC10323109/ /pubmed/37211924 http://dx.doi.org/10.1111/cas.15809 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Retraction
title Retraction
title_full Retraction
title_fullStr Retraction
title_full_unstemmed Retraction
title_short Retraction
title_sort retraction
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323109/
https://www.ncbi.nlm.nih.gov/pubmed/37211924
http://dx.doi.org/10.1111/cas.15809